Answers are grounded in this paper and cite their sources.
COVID-19 is a viral disease secondary to the infection by the SARS-CoV-2 virus that can lead to a severe respiratory distress.The diagnosis of COVID-19 represents a major challenge.Currently the nasopharyngeal or throat swabs for the detection of SARS-CoV-2 RNA by Polymerase Chain Reaction (PCR) is considered the only validated method for the confirmation of SARS-CoV-2 infection.However, this test has some limitations, and its use for the screening of a negative, asymptomatic population remains controversial.The serological essay is a possible alternative both for the diagnosis, when associated with clinical and epidemiological feature, and for the continuous screening of the population and of people with a highrisk profile.We observed in a primary care setting were rapid serological testing has been performed, a possible good correlation with the rapid test and the early detection of SARS-CoV-2 infection.We thus designed the clinical protocol [clinicaltrials.govID Number NCT04316728] presented in this paper to evaluate the clinical performance and the real effectiveness of the serological rapid test for the screening and monitoring of Covid-19 in a pool of negative asymptomatic high-risk population in a primary care setting.
No takes yet. Share an insight, caveat, or question.
Capello et al. (2020) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: